Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review.
Nepal G, Khurana M, Bucheli DH, Bhandari S, Joshi U, Bhagat R, Rehrig JH, Pudasainee P, Shing YK, Ortiz JF, Ojha R, Gajurel BP, Quinonez J, Ruxmohan S, Albert T, Licata S, Stien J.
Nepal G, et al. Among authors: ruxmohan s.
Neurol Int. 2022 Jan 11;14(1):99-108. doi: 10.3390/neurolint14010009.
Neurol Int. 2022.
PMID: 35076567
Free PMC article.
Review.